The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury

Acta Anaesthesiologica Scandinavica

Volumn 48, Issue 4, 2004, Pages 498-506

  Kvarnström, Ann ^a   Karlsten, R ^a   Quiding, H ^b   Gordh, T ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Ketamine; Lidocaine; Neuropathic pain; Side effects; Somatosensory assessments; Spinal cord injury; VAS scoring

Indexed keywords

BACLOFEN; CODEINE; DEXTROPROPOXYPHENE; KETAMINE; KETOBEMIDONE; LIDOCAINE; PARACETAMOL; PLACEBO; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANALGESIA; ANESTHESIOLOGICAL TECHNIQUES; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INFUSION; FEMALE; HEARING DISORDER; HUMAN; MALE; NAUSEA; NEUROPATHIC PAIN; PAIN ASSESSMENT; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; SPINAL CORD INJURY; TREATMENT OUTCOME; VISUAL ANALOG SCALE; VISUAL DISORDER;

ADULT; ANALGESICS; ANALYSIS OF VARIANCE; ANESTHETICS, LOCAL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INFUSIONS, INTRAVENOUS; KETAMINE; LIDOCAINE; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PHYSICAL STIMULATION; SPINAL CORD INJURIES; TEMPERATURE SENSE; TIME FACTORS; TREATMENT OUTCOME;

EID: 1942502308     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2003.00330.x     Document Type: Article

References (54)

1. Riddoch G. The reflex functions of the completely divided spinal cord in man, compared with those associated with less severe lesions. Brain 1917; 40: 264-402.
2. Pollock LJ, Brown M, Boshes B. Pain beow the level of injury of the spinal cord. Arch Neurol Psychiatry 1951; 65: 319-22.
3. Davis L, Martin J. Studies upon spinal cord injuries; the nature and treatment of pain. J Neurosurg 1967; 4: 483-91.
4. Guttman L. Disturbances of sensibility. In: Guttman L, ed. Spinal Cord Injuries: Comprehensive Management and Research, 2nd edn. Oxford, UK: Blackwell Scientific Publications, 1976: 280-94.
5. Levi R. The Stockholm spinal cord injury study: 1. Medical problems in a regional SCI population. Paraplegia 1995; 33: 308-15.
6. New PW. A survey of pain during rehabilitation after acute spinal cord injury. Spinal Cord 1997; 35: 658-63.
7. Stormer S. Chronic pain/dysaesthesiae in spinal cord injury patients: results of a multicentre study. Spinal Cord 1997; 35: 446-55.
8. Siddall PJ. Pain report and the relationship of pain to physical factors in the first 6 months following spinal cord injury. Pain 1999; 81: 187-97.
9. Siddall P, Yezierski R, Loeser JD. Taxonomy and epidemiology of spinal cord injury pain. In: Yezierski R, Burchiel KJ, eds. Spinal Cord Injury Pain: Assesment, Mechanisms, Mangement. Seattle, WA: IASP Press, 2002: 9-24.
10. Finnerup NB. Pain and dysesthesia in patients with spinal cord injury: a postal survey. Spinal Cord 2001; 39: 256-62.
11. Murphy D. Pain treatment satisfaction in spinal cord injury. Spinal Cord 2001; 39: 44-6.
12. Dickenson AH, Sullivan AF. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology 1987; 26: 1235-8.
13. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991; 44: 293-9.
14. Backonja M, Arndt G, Gombar KA, Check B, Zimmermann M. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 1994; 56: 51-7.
15. Eide PK, Jorum E, Stubhaug A, Bremnes J, Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine. a double-blind, cross-over comparison with morphine and placebo. Pain 1994; 58: 347-54.
16. Felsby S, Nielsen J, Arendt-Nielsen L, Jensen TS. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. Pain 1996; 64: 283-91.
17. Max MB. Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo. Clin Neuropharmacol 1995; 18: 360-8.
18. Eide PK. Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation. Neurosurgery 1995; 37: 1080-7.
19. Hao JX. Systemic tocainide relieves mechanical hypersensitivity and normalizes the responses of hyperexcitable dorsal horn wide-dynamic-range neurons after transient spinal cord ischemia in rats. Exp Brain Res 1992; 91: 229-35.
20. Yezierski RP. Pain following spinal cord injury: the clinical problem and experimental studies. Pain 1996; 68: 185-94.
21. Eide PK. Pathophysiological mechanisms of central neuropathic pain after spinal cord injury. Spinal Cord 1998; 36: 601-12.
22. Vierck CJ Jr Pain following spinal cord injury: animal models and mechanistic studies. Pain 2000; 89: 1-5.
23. Woolf CJ. The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord. Pain 1985; 23: 361-74.
24. Bach FW. The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy. Pain 1990; 40: 29-34.
25. Pertovaara A. Lidocaine in the rostroventromedial medulla and the periaqueductal gray attenuates allodynia in neuropathic rats. Neurosci Lett 1996; 218: 127-30.
26. Loubser PG. Diagnostic spinal anaesthesia in chronic spinal cord injury pain. Paraplegia 1991; 29: 25-36.
27. Attal N, Gaude V, Brasseur L et al. Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study. Neurology 2000; 54: 564-74.
28. Siddall PJ, Yerzierski RP, Loeser JD. Pain following spinal cord injury: clinical features, prevalence and taxonomy. IASP Newsletter. 2000a: 3-7.
29. Roden D, Woosley R. Antiarrythmic drugs. In: Wood M, Wood A, eds. Drugs and Anesthesia, Pharamcology for Anesthesiologists. Baltimore, MD: William and Wilkins, 1990: 461-91.
30. Marchettini P. Lidocaine test in neuralgia. Pain 1992; 48: 377-82.
31. Wallace MS, Dyck JB, Rossi SS, Yaksh TL. Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury. Pain 1996; 66: 69-77.
32. Huskinsson EC. Measurement of pain. Lancet 1974; 2: 1127-31.
33. Moore A. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics. Pain 1996; 66: 229-37.
34. Fruhstorfer H, Lindblom U, Schmidt WC. Method for quantitative estimation of thermal thresholds in patients. J Neurol Neurosurg Psychiatry 1976; 39: 1071-5.
35. Ditunno J, Young W, Donovan W. The International Standards Booklet for Neurological and Functional Classification of Spinal Cord Injury. Paraplegia 1994; 32: 70-80.
36. Leung A, Wallace MS, Ridgeway B, Yaksh T. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain. Pain 2001; 91: 177-87.
37. Kvarnström A, Karlsten R, Quiding H, Emanuelsson B-M, Gordh T. The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain. Acta Anaesthesiol Scand 2003; 48: 868-77.
38. Yamamoto T. Pharmacological classification of central post-stroke pain: comparison with the results of chronic motor cortex stimulation therapy. Pain 1997; 72: 5-12.
39. Kastrup J, Petersen P, Dejgard A, Angelo HR, Hilsted J. Intravenous lidocaine infusion - a new treatment of chronic painful diabetic neuropathy? Pain 1987; 28: 69-75.
40. Rowbotham MC. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991; 41: 1024-8.
41. Galer BS, Harle J, Rowbotham MC. Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective study. J Pain Symptom Manage 1996; 12: 161-7.
42. Backonja M, Gombar K. Response of central pain syndromes to intravenous lidocaine. J Pain Symptom Manage 1992; 7: 172-8.
43. Edmondson EA, Simpson Jr RK, Stubler DK, Beric A. Systemic lidocaine therapy for poststroke pain. South Med J 1993; 86: 1093-6.
44. Baranowski AP, De Courcey J, Bonello E. A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia. J Pain Symptom Manage 1999; 17: 429-33.
45. Dimitrijevic MR. Residual motor functions in spinal cord injury. In: Waxman SG, ed. Functional Recovery in Neurological Disease. Advances in Neurology. New York, NY: Raven Press, 1988: 139-155.
46. Beric A, Dimitrijevic M, Light JK. Pain in spinal cord injury with occult caudal lesion. Eur J Pain 1992; 13: 1-7.
47. Beric A. Central pain: 'New' syndromes and their evaluation. Muscle Nerve 1993; 16: 1017-24.
48. Davidoff G, Roth E, Guarracini M, Sliwa J, Yarkony G. Function-limiting dysaesthetic pain syndrome among traumatic spinal cord injury patients: a cross-sectional study. Pain 1987; 29: 39-48.
49. Beric A. Central dysesthesia syndrome in spinal cord injury patients. Pain 1988; 34: 109-16.
50. Summers JD, Rapoff MA, Varghese G, Porter K, Palmer RE. Psychosocial factors in chronic spinal cord injury pain. Pain 1991; 47: 183-9.
51. Siddall PJ, McClelland JM, Rutkowski SB, Cousins MJ. A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury. Pain 2003; 103: 249-57.
52. Melzack Loeser JD. Phantom body pain in paraplegics: Evidence for a central 'pattern generating mechanism' for pain. Pain 1978; 4: 195-210.
53. Boivie J. Central post-stroke pain - a study of the mechanisms through analyses of the sensory abnormalities. Pain 1989; 37: 173-85.
54. Eide PK. Somatosensory findings in patients with spinal cord injury and central dysaesthesia pain. J Neurol Neurosurg Psychiatry 1996; 60: 411-5.